Skip to content

SCHEDULE 13G/AAccepted Feb 12, 10:19 AM ET

REVELATION BIOSCIENCES, INC. SCHEDULE 13G/A

AXA IM Prime Impact Master Fund I SCA SICAV-RAIF

Accepted (ET)

10:19 AM

Feb 12, 2024

Filed

Feb 12, 2024

Documents

1

Size

14.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.